Jing Qiang
Président chez Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
Fortune : 17 M $ au 31/05/2024
Postes actifs de Jing Qiang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
 Suzhou Sinovent Pharmaceutical Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Sinovent Pharmaceutical Technology Co. Ltd. is a private company that focuses on researching, developing, producing, and commercializing therapeutic drugs. The company is based in Suzhou, China. | Président | - | - |
Historique de carrière de Jing Qiang
Anciens postes connus de Jing Qiang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Directeur/Membre du Conseil | 23/12/2019 | 14/12/2021 |
| President | 01/03/2018 | 30/11/2020 | |
| CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED | Directeur Général | 01/07/2010 | 01/03/2018 |
China International Capital Corp. Ltd. (Broker)
 China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China. | Analyst-Equity | - | - |
Formation de Jing Qiang
| Shanghai Jiao Tong University | Undergraduate Degree |
| Fudan University | Graduate Degree |
Statistiques
Internationale
| Chine | 6 |
| Hong Kong | 2 |
Opérationnelle
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
| Director/Board Member | 1 |
Sectorielle
| Consumer Services | 3 |
| Finance | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SINOMAB BIOSCIENCE LIMITED | Health Technology |
| CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED | Finance |
| Entreprise privées | 2 |
|---|---|
Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
Suzhou Sinovent Pharmaceutical Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Sinovent Pharmaceutical Technology Co. Ltd. is a private company that focuses on researching, developing, producing, and commercializing therapeutic drugs. The company is based in Suzhou, China. | Commercial Services |
China International Capital Corp. Ltd. (Broker)
China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China. | Finance |
- Bourse
- Insiders
- Jing Qiang
- Expérience
